{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.12.1044","meta":{"versionId":"20","lastUpdated":"2022-03-01T01:04:38.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044","version":"20170504","name":"Influenza Vaccine Administered","status":"active","date":"2022-03-07T11:14:02-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115"]}]},"expansion":{"identifier":"urn:uuid:a4cb3187-994a-4fbb-8985-9f23cf7573c9","timestamp":"2022-06-10T08:49:31-04:00","total":13,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"786847005","display":"Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"86198006","display":"Administration of vaccine product containing only Influenza virus antigen (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90655","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90657","display":"Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90661","display":"Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90662","display":"Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90673","display":"Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90674","display":"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90685","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90686","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90687","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90688","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90756","display":"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"}]}}